Danghui Yu

529 total citations
8 papers, 369 citations indexed

About

Danghui Yu is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Danghui Yu has authored 8 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Danghui Yu's work include MicroRNA in disease regulation (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and RNA modifications and cancer (1 paper). Danghui Yu is often cited by papers focused on MicroRNA in disease regulation (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and RNA modifications and cancer (1 paper). Danghui Yu collaborates with scholars based in China and United States. Danghui Yu's co-authors include Ming-hua Zhu, Chenyan Zhao, Min Shi, Shu‐Hui Zhang, Qinghua Liu, Jing Zhang, Can-rong Ni, Lina Liu, Hongyu Yu and Li Wang and has published in prestigious journals such as PLoS ONE, Cancer Letters and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Danghui Yu

8 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danghui Yu China	7	255	169	97	63	35	8	369
Shengqi Hou United States	8	230 0.9×	113 0.7×	58 0.6×	29 0.5×	22 0.6×	12	295
Xiangbin Wu China	6	146 0.6×	105 0.6×	120 1.2×	64 1.0×	18 0.5×	9	287
Yuyan Xu China	11	187 0.7×	74 0.4×	75 0.8×	77 1.2×	22 0.6×	39	333
Alexandros P. Drainas United States	8	192 0.8×	80 0.5×	141 1.5×	74 1.2×	41 1.2×	13	365
Anjali Geethadevi United States	9	190 0.7×	102 0.6×	79 0.8×	45 0.7×	22 0.6×	17	304
M Yamada Japan	7	281 1.1×	63 0.4×	122 1.3×	54 0.9×	21 0.6×	13	392
Yukio Yamano Japan	10	235 0.9×	82 0.5×	110 1.1×	35 0.6×	57 1.6×	17	343
Linden Lyne United Kingdom	12	209 0.8×	52 0.3×	70 0.7×	74 1.2×	12 0.3×	16	361
Mianen Sun United States	8	279 1.1×	106 0.6×	108 1.1×	26 0.4×	35 1.0×	17	357
Andressa Gois Morales Brazil	11	250 1.0×	133 0.8×	70 0.7×	14 0.2×	79 2.3×	13	353

Countries citing papers authored by Danghui Yu

Since Specialization

Citations

This map shows the geographic impact of Danghui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danghui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danghui Yu more than expected).

Fields of papers citing papers by Danghui Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danghui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danghui Yu. The network helps show where Danghui Yu may publish in the future.

Co-authorship network of co-authors of Danghui Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Danghui Yu. A scholar is included among the top collaborators of Danghui Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danghui Yu. Danghui Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Zhang, Jing, Xiongfei Xu, Min Shi, et al.. (2017). CD13^hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. OncoImmunology. 6(2). e1258504–e1258504. 58 indexed citations

2.

Zhang, Jing, Chenyan Zhao, Shu‐Hui Zhang, et al.. (2013). Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Oncology Reports. 31(3). 1157–1164. 68 indexed citations

3.

Zhao, Chenyan, Jing Zhang, Shu‐Hui Zhang, et al.. (2013). Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncology Reports. 30(1). 276–284. 80 indexed citations

4.

Liu, Qinghua, et al.. (2011). Surviving cells after treatment with gemcitabine or 5-fluorouracil for the study of de novo resistance of pancreatic cancer. Cancer Letters. 314(1). 119–125. 14 indexed citations

5.

Li, Yongmei, Zhi Zhu, Shu‐Hui Zhang, et al.. (2011). ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth. PLoS ONE. 6(3). e17794–e17794. 103 indexed citations

6.

Zhu, Ming-hua & Danghui Yu. (2011). Fluctuations in the rate of autopsy in China.. PubMed. 124(20). 3403–7. 17 indexed citations

7.

Chen, Ying, Guanzhen Yu, Danghui Yu, & Ming-hua Zhu. (2010). PKCα-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1. Journal of Experimental & Clinical Cancer Research. 29(1). 104–104. 27 indexed citations

8.

Yu, Danghui, et al.. (2009). [Hepatitis B virus X protein inhibits hepatoma cell growth in vitro through p14(ARF)-dependent and p14(ARF)-independent pathways].. PubMed. 29(6). 1089–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact